- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Aslan Pharmaceuticals Ltd ADR is a biotechnology business based in the US. Aslan Pharmaceuticals Ltd ADR shares (ASLN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Aslan Pharmaceuticals Ltd ADR employs 35 staff and has a trailing 12-month revenue of around $12 million.
What's in this guide?
- ASLN shares summary
- Compare share dealing platforms
- Is ASLN stock a buy or sell?
- Stock performance over time
- Can I short ASLN shares?
- Aslan Pharmaceuticals Ltd ADR's financials
- How volatile are ASLN shares?
- Does Aslan Pharmaceuticals Ltd ADR pay a dividend?
- Have ASLN shares ever split?
- Other common questions
Our top picks for where to buy Aslan Pharmaceuticals Ltd ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Aslan Pharmaceuticals Ltd ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ASLN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Aslan Pharmaceuticals Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aslan Pharmaceuticals Ltd ADR stock price (NASDAQ: ASLN)
Use our graph to track the performance of ASLN stocks over time.Aslan Pharmaceuticals Ltd ADR shares at a glance
Information last updated 2024-10-27.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.48 - $15.20 |
| 50-day moving average | $1.61 |
| 200-day moving average | $3.89 |
| Wall St. target price | $72.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-16.00 |
Is it a good time to buy Aslan Pharmaceuticals Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aslan Pharmaceuticals Ltd ADR price performance over time
Historical closes compared with the close of $0 from 2024-07-29
| 1 week (2024-10-19) | N/A |
|---|---|
| 1 month (2024-09-26) | N/A |
| 3 months (2024-07-29) | 0 |
| 6 months (2024-04-30) | -100.00% |
| 1 year (2023-10-30) | -100.00% |
|---|---|
| 2 years (2022-10-28) | -100.00% |
| 3 years (2021-10-29) | 1.68 |
| 5 years (2019-10-30) | 1.62 |
Aslan Pharmaceuticals Ltd ADR financials
| Revenue TTM | $12 million |
|---|---|
| Gross profit TTM | $79.8 million |
| Return on assets TTM | -53.69% |
| Return on equity TTM | -426.64% |
| Profit margin | -291.89% |
| Book value | $-7.70 |
| Market Capitalization | $1.7 million |
TTM: trailing 12 months
Aslan Pharmaceuticals Ltd ADR share dividends
We're not expecting Aslan Pharmaceuticals Ltd ADR to pay a dividend over the next 12 months.
Have Aslan Pharmaceuticals Ltd ADR's shares ever split?
Aslan Pharmaceuticals Ltd ADR's shares were split on a 1:8 basis on 2 July 2024 . So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aslan Pharmaceuticals Ltd ADR shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Aslan Pharmaceuticals Ltd ADR shares which in turn could have impacted Aslan Pharmaceuticals Ltd ADR's share price.
Aslan Pharmaceuticals Ltd ADR share price volatility
Over the last 12 months, Aslan Pharmaceuticals Ltd ADR's shares have ranged in value from as little as $0.475 up to $15.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aslan Pharmaceuticals Ltd ADR's is 1.399. This would suggest that Aslan Pharmaceuticals Ltd ADR's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Aslan Pharmaceuticals Ltd ADR overview
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises eblasakimab (ASLAN004), a monoclonal antibody that targets the IL-13 receptor a1 subunit which is under Phase 2 developed for the treatment of atopic dermatitis and other immunology indications; and farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase currently under Phase 2 clinical trials for the treatment of autoimmune diseases. It has research collaboration agreement with Zenyaku Kogyo Co. , Ltd. for the development and commercialization of eblasakimab in atopic dermatitis and all other indications in Japan. The company was founded in 2010 and is headquartered in Singapore. .
Frequently asked questions
nullWhat percentage of Aslan Pharmaceuticals Ltd ADR is owned by insiders or institutions?
Currently 0.138% of Aslan Pharmaceuticals Ltd ADR shares are held by insiders and 13.207% by institutions. How many people work for Aslan Pharmaceuticals Ltd ADR?
Latest data suggests 35 work at Aslan Pharmaceuticals Ltd ADR. When does the fiscal year end for Aslan Pharmaceuticals Ltd ADR?
Aslan Pharmaceuticals Ltd ADR's fiscal year ends in December. Where is Aslan Pharmaceuticals Ltd ADR based?
Aslan Pharmaceuticals Ltd ADR's address is: 3 Temasek Avenue, Singapore, Singapore, 039190 What is Aslan Pharmaceuticals Ltd ADR's ISIN number?
Aslan Pharmaceuticals Ltd ADR's international securities identification number is: US04522R1014 What is Aslan Pharmaceuticals Ltd ADR's CUSIP number?
Aslan Pharmaceuticals Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 04522R101
More resources on Finder
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question